Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia

Abstract Objective Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors are a new class of anti-anemia agents. We retrospectively evaluated the safety and efficacy of HIF-PH inhibitors in patients with heart failure (HF) complicated by anemia associated with chronic kidney disase. HIF-PH...

Full description

Bibliographic Details
Main Authors: Takahiro Kambara, Rei Shibata, Yuusuke Sakamoto, Teruhiro Sakaguchi, Hiroyuki Osanai, Yoshihito Nakashima, Hiroshi Asano, Toyoaki Murohara, Masayoshi Ajioka
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Research Notes
Subjects:
Heart failure
HIF-PH inhibitor
NT-proBNP
Renal anemia
Ferritin
TSAT
Online Access:https://doi.org/10.1186/s13104-024-06726-7

Internet

https://doi.org/10.1186/s13104-024-06726-7

Similar Items